| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Compass Therapeutics, Inc. (CMPX) has 12 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. CMPX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 6.60M | $13.34M | - | |
| Other | 1.00M | $2.02M | - | |
| Other | 1.00M | $2.02M | - | |
| CFO | 525.0K | $1.06M | - | |
| Other | 397.5K | $803.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2022 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 15,000 | $2.58 | $38,700.00 | +0.3% | +19.7% | +1.5% | |
| Jun 21, 2022 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 20,000 | $2.80 | $56,000.00 | +0.4% | +2.4% | +16.4% | |
| Jun 16, 2022 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 20,000 | $2.34 | $46,800.00 | +0.4% | +36.4% | +25.1% | |
| Jun 13, 2022 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 30,000 | $2.29 | $68,700.00 | +0.6% | +48.3% | +63.7% | |
| Jun 6, 2022 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 30,000 | $2.83 | $84,900.00 | +0.6% | +12.3% | +12.3% | |
| Jun 1, 2022 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 20,000 | $3.03 | $60,600.00 | +0.4% | +2.4% | +1.4% | |
| May 26, 2022 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 20,000 | $3.04 | $60,800.00 | +0.4% | +1.7% | +1.7% | |
| May 23, 2022 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 18,355 | $2.72 | $49,925.60 | +0.4% | +10.5% | +21.7% | |
| May 17, 2022 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 20,215 | $2.47 | $49,931.05 | +0.4% | +18.4% | +32.2% | |
| May 13, 2022 | Gordon Carl L74 | Director, 10% Owner | Buy | 192,516 | $2.18 | $420,481.68 | +0.4% | +8.3% | +28.1% |